Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huaming Tan

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Journal of Drugs in Dermatology : JDD|May 12, 2016
Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 TrialsM Alan Menter, Kim A Papp, Jennifer Cather, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2016
Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 studyJames Krueger, James D Clark, Mayte Suárez-Fariñas, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Journal of Drugs in Dermatology : JDD|May 12, 2016
Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 TrialsM Alan Menter, Kim A Papp, Jennifer Cather, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2016
Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 studyJames Krueger, James D Clark, Mayte Suárez-Fariñas, et al.
Pageof 4